NEW YORK (GenomeWeb) – Knome today announced a sponsorship agreement to offer its next-generation sequencing data analysis system to startups in LabCentral's facility for free.
LabCentral was founded in late 2013 as a shared laboratory space to help launch high-potential life sciences and biotech startups. It currently hosts 25 companies in its Cambridge, Mass.-based facility and anticipates being at full capacity in the fall, Knome said.
Companies there will be able log into Knome's KnoSys Informatics and Genomic Interpretation System, located at the company's Cambridge facility, then upload their samples, analyze them, and export results. The startups also will have access to Knome's experts for training and support.
KnoSys is for clinical and translational medicine applications and offers a scalable, production-grade, customizable system for customers who want to bring in house the analysis of their NGS data. The solution is a fully integrated system for alignment, variant calling, annotation, multisample comparison, interpretation, variant classification, report content drafting, and storage of human genome sequence data. Version 3 of KnoSys was released last month.